Urinary NGAL levels were measured in urine samples collected from patients in the TAC–AKI and non-AKI groups immediately before tacrolimus administration on Postoperative Day 1 (Figure 1A) and during tacrolimus treatment (Postoperative Day 7 or 14) (Figure 1B). The gene discussed is LCN2; the disease is persistent truncus arteriosus.